Palatine like phospholipase domain containing 3 (PNPLA-3) [15,16,17] |
Increased risk of hepatic steatosis, incidence of NASH and severity of fibrosis |
Farnesyl diphosphate farnesyl transferase I (FDFT1) [19] |
Increased severity of NAFLD activity score |
Collagen type XIII alpha 1 (COL13A1) [19] |
Increased severity of fibrosis |
Neurocan (NCAN) [19] |
Increased risk hepatic steatosis |
Glucokinase regulatory protein (GCKR) [19] |
Increased risk hepatic steatosis |
Transmembrane 5 superfamily member 2 (TM6SF2) [21] |
Increased risk for hepatic fibrosis |